Therapies With Different Mechanisms of Action Available for Low-Risk MDSByBertrand Y. Tuan, MDDecember 3rd 2024Bertrand Y. Tuan, MD, discusses the therapies relevant to patients with low-risk myelodysplastic syndrome.